| abstract |
The present invention relates to a chitosan-coated injection hemostatic needle into which a catechol group and an oxidized catechol group are inserted and crosslinked. The bleeding stop injection needle according to the present invention can prevent bleeding during and after injection, and thus can be effectively used for injection not only in coagulopathy patients, including diabetic patients, anticancer patients, and haemophilia patients, Those who have a reduced ability to stop the bleeding, but also in patients who show responses to reject blood, and children. Figure 1. |